Claim Missing Document
Check
Articles

Found 2 Documents
Search

Profile Of Patient Diagnosed With Depression In Bandar Lampung In 2023 (BPJS Kesehatan Sample Data From 2024): A Descriptive Study Syaripah Ulandari; Yulianasari Pulungan; Dwi Ismayati; Made Laksmi Meiliana
International Journal of Health Systems and Policy Vol. 2 No. 1 (2026): Vol 2 No 1 June 2026
Publisher : Ponpes As-Salafiyyah Asy-Syafi'iyyah

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.71305/ijhsp.v2i1.1622

Abstract

Depression is a major global public health concern and a leading cause of disability worldwide, affecting individuals across various demographic groups. Despite its high burden, local descriptive data on depression remain limited, particularly in Bandar Lampung. This study aims to describe the sociodemographic profile of patients diagnosed with depression in Bandar Lampung in 2023 using BPJS Kesehatan sample data. This study employed a descriptive, observational, cross-sectional design using secondary data from the 2023 BPJS Kesehatan dataset. The sample included patients diagnosed with depression based on ICD-10 codes F32 and F33 who accessed referral healthcare facilities (FKRTL). A total of 41 patients from Bandar Lampung were included after data cleaning. Descriptive statistical analysis was conducted to summarize patient characteristics, including diagnosis type, generation, gender, participant segmentation, marital status, and healthcare costs. The results showed that the most common diagnosis was unspecified depressive episode (F329) (31.71%). The majority of patients were from Generation Z (41.46%), female (85.37%), and formally employed participants (31.71%). Most patients were married (53.66%). The total healthcare cost for depression cases reached IDR 10,929,600. These findings highlight the predominance of depression among younger individuals, women, and working populations. In conclusion, depression in Bandar Lampung is influenced by demographic and socioeconomic factors, with higher prevalence observed among vulnerable groups such as Generation Z and women. These findings underscore the need for improved mental health screening, targeted interventions, and strengthened healthcare system support to address depression effectively. Further studies with larger, more comprehensive datasets are recommended.
Efficacy and Safety of Antihypertensive Drugs in Chronic Kidney Disease Patients at Menggala Regional General Hospital Denny Ardhianto; Made Laksmi Meiliana; Dwi Ismayati; Syaripah Ulandari; Okta Puspita; Rena Oktaviana
Jurnal Ilmu Farmasi dan Farmasi Klinik Vol. 23 No. 1 (2026): Jurnal Ilmu Farmasi dan Farmasi Klinis (JIFFK)
Publisher : Universitas Wahid Hasyim Semarang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.31942/jiffk.v23i1.14983

Abstract

Chronic kidney disease (CKD) is a progressive condition characterized by a gradual decline in glomerular filtration rate, often accompanied by hypertension, necessitating antihypertensive therapy. This study aimed to evaluate the effectiveness of antihypertensive drugs in achieving blood pressure targets (<140/90 mmHg or a mean arterial pressure reduction of ≥20 mmHg) and to identify the incidence of adverse effects in CKD patients at Menggala Regional General Hospital during 2024. A retrospective observational study was conducted using medical records from 199 CKD inpatients selected via purposive sampling. Data analysis employed descriptive statistics, paired t-tests for effectiveness, and chi-square tests for associations between drug types. Results indicated that combination therapy with furosemide IV, candesartan, and amlodipine was the most common (77.4%) and demonstrated effectiveness in 50.8% of cases (p=0.01). Adverse effects occurred in only 1.0% of patients, primarily peripheral edema. The findings underscore the efficacy of combination therapies involving diuretics, ARBs, and CCBs in managing hypertension in CKD, with minimal adverse events. This research provides valuable insights for optimizing antihypertensive regimens in similar settings.